DEPLOYDatabase

Robot model

Motif BCI

Wirelessly powered implantable BCI delivering targeted brain stimulation for treatment-resistant depression.

Manufacturer
Motif Neurotech
Form factor
biometric
Maturity
pilot
Lifecycle
active
Deployments
2

Deploy Watch

Track Motif BCI on Deploy.

We notify you when a verified state change lands on the record, not when the company issues a claim.

Key facts

DOT implant (reported, Apr 2026)

A wirelessly powered, blueberry-sized implant in the skull above the dura that stimulates depression-linked circuits without touching the brain.

FDA feasibility study (reported, Apr 2026)

FDA cleared an early feasibility study for adults with treatment-resistant depression; the exemption came four years after founding, per Rice University.

Study sites and population (reported, Apr 2026)

Sites include Baylor College of Medicine and Massachusetts General Brigham; Motif puts the patient group at nearly 3 million Americans.

Data & sources

Web sources

1

1 source backing this record.View all →

Pricing

No verified price is on record for Motif BCI. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

Deployments (2)

Motif BCI on the deployment map

View the global map

Where Motif BCI is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Motif BCI.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (1)

  1. https://news.rice.edu/news/2026/brain-computer-interface-based-rice-research-wins-fda-approval-first-clinical-trial

Mentioned on (1)

Registry pages whose text names Motif BCI.

Companies (1)

Motif Neurotech

Common questions

What is Motif BCI?
Wirelessly powered implantable BCI delivering targeted brain stimulation for treatment-resistant depression.
How much does Motif BCI cost?
Motif BCI's price is not publicly disclosed. DEPLOY has no verified price on record for Motif BCI from Motif Neurotech. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Motif BCI actually deployed in the real world?
Yes. Motif BCI is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Motif BCI?
Motif BCI is made by Motif Neurotech, based in Houston, Texas, USA, founded in 2022.
Where is Motif BCI deployed?
2 verified deployments of Motif BCI are on the DEPLOY registry, including at United States, Germany, Europe.
Can you buy Motif BCI?
Motif BCI is in pilot deployments with named customers and is not yet broadly for sale.
What are alternatives to Motif BCI?
On the DEPLOY registry, comparable biometric robots to Motif BCI include Blackrock Neuroport Array, Synchron Stentrode, BrainQ Non-Invasive BCI, Neko Body Scan.
How does Motif BCI compare to Blackrock Neuroport Array?
Motif BCI and Blackrock Neuroport Array (Blackrock Neurotech · 5 deployments) are both biometric robots on the DEPLOY registry. Motif BCI has 2 verified deployments on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Motif BCI a top biometric?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Motif BCI ranks in roughly the top 58% of biometric models tracked by the registry.
What is Motif BCI's maturity stage?
Motif BCI is at the pilot stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Pilot stage means at least one named-customer trial deployment is verified.
Is Motif BCI safe?
Motif BCI has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 1 source (no primary) · last reviewed 2026-10-12

Verification posture

Verified

Low confidence

Review state

Stable

Last reviewed 2026-10-12

Maturity + lifecycle

Maturity stage: pilot

Lifecycle: active

Architectural position

Cohort: biometric

Sources by quality tier

1
unclassified
Unclassified source

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Motif BCI.

Recent coverage

Motif BCI in third-party press